Team:Exeter/Applications

The medical applications of custom made polysaccharides are vast, ranging from improved drug delivery to antiseptic wound gel. Perhaps the greatest benefit would be in vaccine use. Polysaccharide-based vaccines (either normal or conjugated to a protein) are a vaccine subunit and provide effective immunity to diseases such as Haemophilus influenzae type b. The ability to produce novel polysaccharides quickly could lead to very fast vaccine production in the case of an epidemic. Vaccine types could be 'stored' and then, in effect 'grown' in a lab for rapid dispatch.

Blood type is determined exclusively by polysaccharides on the surface of blood cells. In the future we envisaged a system by which a donars blood type could be 'masked', and therefore readily induced to the accepters blood despite not matching. This could be achieved by creating a polysaccharide which binds to the donar blood whilst exhibiting the properties of the accepters blood.